1. Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Issue 3 (25th February 2013) Authors: Bonelli, M.; Ferner, E.; Göschl, L.; Blüml, S.; Hladik, A.; Karonitsch, T.; Kiener, H. P.; Byrne, R.; Niederreiter, B.; Steiner, C. W.; Rath, E.; Bergmann, M.; Smolen, J. S.; Scheinecker, C. Journal: Arthritis and rheumatism Issue: Volume 65:Issue 3(2013:Mar.) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Issue 3 (25th February 2013) Authors: Bonelli, M.; Ferner, E.; Göschl, L.; Blüml, S.; Hladik, A.; Karonitsch, T.; Kiener, H. P.; Byrne, R.; Niederreiter, B.; Steiner, C. W.; Rath, E.; Bergmann, M.; Smolen, J. S.; Scheinecker, C. Journal: Arthritis and rheumatism Issue: Volume 65:Issue 3(2013:Mar.) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Haematopoetic TREM2 deficiency modulates atherosclerosis and lipid metabolism. (December 2020) Authors: Porsch, F.; Kiss, M.G.; Goederle, L.; Hendrikx, T.; Hladik, A.; Knapp, S.; Binder, C.J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hematopoietic Trem2 Deficiency Increases Plasma Cholesterol And Triglyceride Levels And Aggravates Atherosclerosis. (August 2019) Authors: Kiss, M.; Porsch, F.; Göderle, L.; Hladik, A.; Knapp, S.; Binder, C.J. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Non-alcoholic steatohepatitis is reflected by levels of systemic soluble TREM2 and limited by the recruitment of TREM2-positive macrophages to areas of lipid-induced tissue damage. (August 2022) Authors: Porsch, F.; Kiss, M.G.; Rajčić, D.; Papac-Milicevic, N.; Goederle, L.; Hladik, A.; Derdak, S.; Shaw, L.E.; Heintz, L.; Paternostro, R.; Farlik, M.; Knapp, S.; Krawczyk, M.; Trauner, M.; Bilban, M.; Wolf, D.; Binder, C.J.; Hendrikx, T. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0040 Realtime Analysis of Monocyte Migration in 3D Synovial Micromass Tissue Cultures. (23rd January 2014) Authors: Byrne, R.; von Dalwigk, K.; Hladik, A.; Steiner, G.; Smolen, J. S.; Kiener, H.; Scheinecker, C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0073 Loss of Tyrosine Kinases Leads to Enhanced Osteoclastogenesis in a Murine Model of Rheumatoid Arthritis. (23rd January 2014) Authors: Bonelli, M.; Blüml, S.; Böhm, C.; Hladik, A.; Goncalvesalves, E.; Ellmeier, W.; Smolen, J. S.; Scheinecker, C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. TREM2 deficiency increases plasma cholesterol and triglyceride levels without influencing lesion formation in LDLR-deficient mice. (August 2018) Authors: Kiss, M.; Porsch, F.S.; Hladik, A.; Göderle, L.; Sharif, O.; Knapp, S.; Binder, C.J. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗